secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001213900-26-037476
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies files prospectus supplement for resale of up to 10.5M shares by selling stockholders
--------------------------------------------------------------------------------

- Filed prospectus supplement covering resale of up to 10,529,417 shares of common stock by selling stockholders.
- Shares registered under existing S-3 shelf effective August 12, 2025.
- No new shares issued; proceeds go to selling stockholders, not the company.
- Legal opinion of Olshan Frome Wolosky LLP on share legality attached as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026037476/0001213900-26-037476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026037476/ea0283924-8k_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-037476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer